Efficacy and Safety of a Fixed-Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Compared With its Components Given Alone: Results of a Phase 3, Open-Label, Randomised, 26-Week, Treat-to-Target Trial in Insulin-Naive Patients With Type 2 Diabetes
As of 1 March 2025, a total of 15 durian chloroplast genomes have been published, with genome sizes around 165 kb, except for D
GLP-1s typically lead to moderate-to-significant weight loss in individuals with obesity people can lose approximately 5% to 15% of their initial body weight
Some people make the mistake of confusing total vial size with dose size
However, more serious issues have also been linked to these drugs, including gallbladder problems, low blood sugar, kidney injury and diabetic retinopathy (damage to the eyes retina)
They show up in clinical trial design, in tolerability profiles, in the types of metabolic benefits each compound delivers, and in the practical timelines for when researchers might actually be able to access them